Latest Insider Transactions at Tekla Healthcare Opportunities Fund (THQ)
This section provides a real-time view of insider transactions for Tekla Healthcare Opportunities Fund (THQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tekla Healthcare Opportunities Fund to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tekla Healthcare Opportunities Fund's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 16
2024
|
Rose Di Martino Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$21,000
$21.3 P/Share
|
|
Apr 09
2024
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
600
+34.32%
|
$11,400
$19.54 P/Share
|
|
Jan 02
2024
|
Todd Reit Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$18,000
$18.44 P/Share
|
|
Dec 28
2023
|
Bill Maher Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$18,000
$18.25 P/Share
|
|
Mar 23
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
69
+11.18%
|
$1,449
$21.68 P/Share
|
|
Jan 26
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
479
+50.0%
|
$10,059
$21.73 P/Share
|
|
Feb 25
2021
|
William S Reardon Director |
BUY
Open market or private purchase
|
Direct |
1,196
+50.0%
|
$23,920
$20.85 P/Share
|